Journal for ImmunoTherapy of Cancer (Nov 2023)
624 Longitudinal scRNAseq profiling of PBMCs from melanoma patients treated with anti-CTLA4 or anti-PD1/CTLA4 combination elucidates mechanisms of immunotherapy resistance
Abstract
No abstracts available.